Defunct Company
Total Trials
3
As Lead Sponsor
0
As Collaborator
Total Enrollment
92
NCT03205462
An Open Study to Assess the Safety and Pharmacokinetics of Fluorothyazinone as a Single-Dose Administration or a Treatment Course in Healthy Volunteers
Phase: Phase 1
Role: Collaborator
Start: Aug 10, 2017
Completion: Dec 15, 2017
NCT04067492
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Evaluation of RPH-104 Administered at Different Doses to Patients With Acute Gout Attack
Phase: Phase 2
Start: Mar 26, 2018
Completion: May 12, 2020
NCT04692766
Study to Evaluate the Efficacy and Safety of RPH-104 Treatment in Patients With Idiopathic Recurrent Pericarditis
Phase: Phase 2/3
Start: Feb 12, 2020
Completion: Mar 22, 2022